Bay Street News, April 11th, 2024

Analysis of eligible1 patients from the sepsis Phase II study (NCT# NCT04612413) In accordance with the study protocol, the safety and […]

Successful completion of TVGN 489’s proof-of-concept clinical trial suggested the ability to target and eliminate a virus in high-risk population […]

LITTLE ROCK, Ark., April 11, 2024 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti” or the “Company”) (Nasdaq: UNIT) announced today […]

CALGARY, Alberta, April 11, 2024 (GLOBE NEWSWIRE) — Parex Resources Inc. (“Parex” or the “Company”) (TSX: PXT) and its strategic […]

SANTA BARBARA, Calif., April 11, 2024 (GLOBE NEWSWIRE) — AppFolio, Inc. (NASDAQ: APPF) today announced that it will report its […]

TORONTO, April 11, 2024 (GLOBE NEWSWIRE) — Consolidated Lithium Metals Inc. (TSXV: CLM | OTCQB: JORFF | FRA: Z36) (“CLM” […]

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of integrated facility services, infrastructure solutions, […]

PHILADELPHIA, April 11, 2024 (GLOBE NEWSWIRE) — Enviri Corporation (NYSE: NVRI) today announced that it will issue its first quarter […]

Vancouver, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) — Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA:UB1) is […]

VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF […]